Early B-cell therapy linked to better MS disease control
For people recently diagnosed with multiple sclerosis (MS), early treatment choices were associated with only slight differences after…
FDA approves new Alzheimer’s blood test that family doctors can order
FDA approves new Alzheimer’s blood test for people over 55. Here’s what it can — and can’t —…
Scientists compared 51 longevity studies to see which aging biomarkers respond most reliably
A large-scale comparison of human longevity studies reveals why some epigenetic clocks detect biological changes far more consistently…
Higher BPA exposure tracked with higher estrogen and progesterone in women
Everyday exposure to plastics, packaged foods, bottled drinks, and cosmetics may be shaping hormone patterns in ways researchers…
Later-life estrogen therapy associated with lower risk of developing dementia
Use of hormone therapy later in life was associated with lower risk of developing dementia, according to a…
Two-gene interaction reveals metastatic risk in breast cancer
Why do some breast cancer patients face a much higher risk of distant metastasis, while others with seemingly…
Microbial metabolites could help improve functional cure rates for hepatitis B
Chronic hepatitis B (CHB) remains a major global challenge. Current therapies suppress HBV but rarely achieve functional cure…
Amyloid beta misfolding predicts Alzheimer’s years before symptoms appear
Widely used Alzheimer’s biomarker P-tau 217 reliably detects the disease only at the clinical stage. The protein misfolding…
Smart ring continuously tracks multiple health biomarkers from finger sweat
Engineers at the University of California San Diego created a smart ring that simultaneously and continuously monitors up to…
Endotrophin may reveal metabolic risks linked to changing body fat
Researchers have identified a biological marker that rises and falls as body fat changes, offering new insight into…
New ctDNA blood test improves personalized prostate cancer treatment
A noninvasive DNA blood test can identify metastatic castration-resistant prostate cancer (mCRPC) patients who are most likely to…
Study sheds light on the prognostic value of blood test for predicting cognitive impairment risk
A blood test for the biomarker phosphorylated tau 217 (p-tau217) recently received federal clearance, but questions have emerged…